Sarepta Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Sarepta Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Sarepta Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was 3.61 %.
  • Sarepta Therapeutics, Inc. annual Return On Assets for 2023 was -17.1 %, a 25.2% increase from 2022.
  • Sarepta Therapeutics, Inc. annual Return On Assets for 2022 was -22.8 %, a 54.3% decline from 2021.
  • Sarepta Therapeutics, Inc. annual Return On Assets for 2021 was -14.8 %, a 22.7% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 3.61 +25.9 Jul 1, 2024 Sep 30, 2024
Q2 2024 1.45 +30.6 Apr 1, 2024 Jun 30, 2024
Q1 2024 0.53 +36.7 Jan 1, 2024 Mar 31, 2024
Q4 2023 -17.1 +5.74 +25.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 -22.2 +0.94 +4.05% Jul 1, 2023 Sep 30, 2023
Q2 2023 -29.1 -12 -70.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -36.2 -23.9 -195% Jan 1, 2023 Mar 31, 2023
Q4 2022 -22.8 -8.03 -54.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -23.2 -5.78 -33.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -17.1 +5.4 +24% Apr 1, 2022 Jun 30, 2022
Q1 2022 -12.3 +12.4 +50.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -14.8 +4.34 +22.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -17.4 +5.62 +24.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -22.5 +0.19 +0.84% Apr 1, 2021 Jun 30, 2021
Q1 2021 -24.7 +7.25 +22.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -19.1 +20.4 +51.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -23 +12.1 +34.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -22.7 +12.2 +35% Apr 1, 2020 Jun 30, 2020
Q1 2020 -31.9 -5.2 -19.5% Jan 1, 2020 Mar 31, 2020
Q4 2019 -39.5 -12.6 -46.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 -35.2 -15.7 -80.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -34.9 -16.3 -87.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -26.7 -9.08 -51.5% Jan 1, 2019 Mar 31, 2019
Q4 2018 -27 -20.3 -308% Oct 1, 2018 Dec 31, 2018
Q3 2018 -19.5 +1.62 +7.69% Jul 1, 2018 Sep 30, 2018
Q2 2018 -18.6 +7.92 +29.9% Apr 1, 2018 Jun 30, 2018
Q1 2018 -17.6 +12.7 +41.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -6.6 +73.9 +91.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 -21.1 +61.6 +74.5% Jul 1, 2017 Sep 30, 2017
Q2 2017 -26.5 +82.5 +75.7% Apr 1, 2017 Jun 30, 2017
Q1 2017 -30.3 +66.3 +68.6% Jan 1, 2017 Mar 31, 2017
Q4 2016 -80.5 +13.9 +14.7% Oct 1, 2016 Dec 31, 2016
Q3 2016 -82.6 +1.1 +1.31% Jul 1, 2016 Sep 30, 2016
Q2 2016 -109 -43.9 -67.5% Apr 1, 2016 Jun 30, 2016
Q1 2016 -96.6 -40 -70.6% Jan 1, 2016 Mar 31, 2016
Q4 2015 -94.3 -50.1 -113% Oct 1, 2015 Dec 31, 2015
Q3 2015 -83.7 -51 -156% Jul 1, 2015 Sep 30, 2015
Q2 2015 -65.1 -27.7 -74% Apr 1, 2015 Jun 30, 2015
Q1 2015 -56.6 -19.4 -52.2% Jan 1, 2015 Mar 31, 2015
Q4 2014 -44.3 +1.76 +3.82% Oct 1, 2014 Dec 31, 2014
Q3 2014 -32.8 +41.8 +56.1% Jul 1, 2014 Sep 30, 2014
Q2 2014 -37.4 +71.4 +65.6% Apr 1, 2014 Jun 30, 2014
Q1 2014 -37.2 +80.8 +68.5% Jan 1, 2014 Mar 31, 2014
Q4 2013 -46 +93.9 +67.1% Oct 1, 2013 Dec 31, 2013
Q3 2013 -74.6 +49.1 +39.7% Jul 1, 2013 Sep 30, 2013
Q2 2013 -109 -79.2 -268% Apr 1, 2013 Jun 30, 2013
Q1 2013 -118 -81.2 -220% Jan 1, 2013 Mar 31, 2013
Q4 2012 -140 Oct 1, 2012 Dec 31, 2012
Q3 2012 -124 Jul 1, 2012 Sep 30, 2012
Q2 2012 -29.6 Apr 1, 2012 Jun 30, 2012
Q1 2012 -36.9 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.